CMA
IART icon

Cedar Mountain Advisors’s Integra LifeSciences IART Stock Holding History

Cedar Mountain Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.36K Hold
410
– – ﹤0.01% 579
2026
Q1 		$3.86K Buy
410
+397
+3,054% +$4.36K ﹤0.01% 723
2025
Q4 		$161 Buy
+13
New +$173 ﹤0.01% 684

Other funds holding IART

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
MAA
Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Cedar Mountain Advisors's IART Position: Q2 2026 in Review

Cedar Mountain Advisors held its Integra LifeSciences (IART) position steady in Q2 2026 at 410 shares worth $7.36K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Cedar Mountain Advisors first reported a position in IART in Q4 2025 and has held it in 3 quarters since. 16 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Cedar Mountain Advisors held 410 shares of Integra LifeSciences worth $7.36K as of Q2 2026.
  • Cedar Mountain Advisors left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #579 holding.
  • Cedar Mountain Advisors first reported a position in Integra LifeSciences in Q4 2025 and has held it in 3 quarters since.
  • 16 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.